Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Lim et al
doi: 10.3389/fcimb.2025.1603442 Received 02 April 2025 Accepted 21 July 2025 Published 11 August 2025 Volume 15 - 2025 Edited by Dinakaran Vasudevan, SKAN Research Trust, India Reviewed by Ieshita Pan, Saveetha University, India Zhaoxiang Wang, First Peoples Hospital of Kunshan, China Updates Copyright 2025 Tao, Yu, Tan, Huang, Huang, Lin and Yu
Remission of bile acid malabsorption symptoms following treatment with the glucagon-like peptide 1 receptor agonist liraglutide
Earlier this month, the medicines watchdog formally expanded its priority focus areas to include unapproved peptide products, making them a compliance priority for 2026
There is no single standard methylene blue dosage
Aqueous humor (AH)
US$ 23.59
US$ 29.03
US$ 25.28
US$ 28.51
US$ 24.98
US$ 25.03
